A. A. Amato

Discovery of (E)-4-styrylphenoxy-propanamide: A dual PPARα/γ partial agonist that regulates high-density lipoprotein-cholesterol levels, modulates adipogenesis, and improves glucose tolerance in diet-induced obese mice.

M. Chorilli, Rafael V. C. Guido, M. Passarelli, 2022, Bioorganic chemistry.

Liraglutide Activates Type 2 Deiodinase and Enhances β3-Adrenergic-Induced Thermogenesis in Mouse Adipose Tissue

S. Wajner, A. Maia, A. A. Amato, 2022, Frontiers in Endocrinology.

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists

Leandro Martínez, Tuo Deng, Alessandro S. Nascimento, 2012, PloS one.

Selective modulator of nuclear receptor PPARγ with reduced adipogenic potential ameliorates experimental nephrotic syndrome

S. Agrawal, B. Kerlin, A. Webb, 2021, bioRxiv.

GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice

F. A. Neves, M. Lima, S. Báo, 2016, PloS one.

PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes.

P. Webb, D. Sieglaff, A. Amato, 2015, Biochemical and biophysical research communications.

Effect of periodontal therapy on insulin resistance in adults with dysglycemia and periodontitis: a systematic review and meta-analysis

A. A. Amato, A. E. M. Marques, Bruna F Greggianin, 2023, Clinical Oral Investigations.